Orphan drugs in Australia

被引：5
|
作者：
Herkes, Geoffrey K. [1 ,2 ,3 ]
机构：
[1] Royal North Shore Hosp, Dept Neurol, St Leonards, NSW, Australia
[2] Univ Sydney, Kolling Inst, Med, Sydney, NSW, Australia
[3] Advisory Comm Prescript Med Therapeut Goods Adm, Canberra, ACT, Australia
来源：
EXPERT OPINION ON ORPHAN DRUGS | 2016年 / 4卷 / 12期
关键词：
Orphan drug program; review; rare diseases; oncology;
D O I：
10.1080/21678707.2016.1257383
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1195 / 1197
页数：3
相关论文
共 50 条
  • [31] Cannabinoids as orphan drugs
    Klotz, Kerstin Alexandra
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2019, 32 (04): : 286 - 291
  • [32] HOMELESS OR ORPHAN DRUGS
    PROVOST, GP
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1968, 25 (11): : 609 - &
  • [33] Orphan drugs of the future?
    不详
    SCIENCE, 2004, 303 (5665) : 1798 - 1798
  • [34] Fostering Orphan Drugs
    Haigney, Susan
    Pharmaceutical Technology, 2022, 2022
  • [35] COMMENT ON ORPHAN DRUGS
    MOON, SB
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (12): : 912 - 912
  • [36] Orphan drugs in epileptology
    Schulze-Bonhage, Andreas
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2019, 32 (04): : 277 - 285
  • [37] DEVELOPMENT OF ORPHAN DRUGS
    SPILKER, B
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (05) : 185 - 188
  • [38] Orphan diseases and treatments including orphan drugs and some orphan indications
    Garattini, S
    EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 117 - 124
  • [39] ORPHAN DRUGS VERSUS ULTRA-ORPHAN DRUGS: PRICE COMPARISON IN ENGLAND
    Chachoua, L.
    Hanna, E.
    Zhou, J.
    Dussart, C.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S107 - S107
  • [40] Ethical dilemmas about orphan drugs for orphan diseases
    Isaacs, David
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (04) : 249 - 250
12345